Study of pain relieving effectiveness of celiac plexus neurolysis against intravenous analgesic during percutaneous biliary surgeries in patients with upper abdominal malignancies

Analgesic efficacy of celiac plexus neurolysis in patients undergoing percutaneous biliary intervention with upper abdominal malignancies - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/077073

Enrollment

Registered

2024-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C221- Intrahepatic bile duct carcinoma Health Condition 2: C170- Malignant neoplasm of duodenum Health Condition 3: C23- Malignant neoplasm of gallbladder Health Condition 4: C24- Malignant neoplasm of other and unspecified parts of biliary tract Health Condition 5: C259- Malignant neoplasm of pancreas, unspecified Health Condition 6: C169- Malignant neoplasm of stomach, unspecified

Interventions

Intervention1: Celiac Plexus Neurolysis: Percutaneous CT guided retrocrural space injection of 10% liquid phenol in celiac ganglion leading to abolishment of pain sensation arising from celiac plexus

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adults with upper abdominal malignancy 2)Should have pain (score in NRS equals or more than 7 out of 10) 3) Should have biliary dilatation and clinical jaundice

Exclusion criteria

Exclusion criteria: Ascites, Hepatic encephalopathy, Patient denial, Active biliary infection

Design outcomes

Primary

Measure	Time frame
Reduction in pain intensity in terms of NRS scoreTimepoint: Immediate and 1 day post op	—

Secondary

Measure	Time frame
Complication rateTimepoint: Day 0	—

Countries

India

Contacts

Public ContactDr Vivek Patre

Pt. J.N.M. Medical college Raipur

ghanshyamverma450@gmail.com7770848303

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026